<DOC>
	<DOCNO>NCT00902616</DOCNO>
	<brief_summary>Patients diabetes dysfunction line artery lead impaired circulation small blood vessel . This think secondary reduced chemical blood viz : nitric oxide . This chemical derive amino acid ( protein ) L-arginine . Therefore , researcher investigate whether give patient L-arginine ( versus dummy powder ) would improve blood flow small blood vessel low limbs patient damage nerve ( neuropathy ) .</brief_summary>
	<brief_title>Effect Arginine Microcirculation Patients With Diabetes</brief_title>
	<detailed_description>Peripheral neuropathy one common complication diabetes mellitus ( DM ) prevalence around 30 - 45 % . In addition , diabetic patient increase risk macrovascular disease , well complication retinopathy nephropathy . The majority patient develop peripheral neuropathy 10-20 year onset diabetes , important cause foot ulceration , Charcot joint , amputation increase morbidity mortality . In view cost National Health Service 1987 stagger £13.5 million . Therefore urgent need prevention diabetic neuropathy sequela . The exact pathogenesis diabetic neuropathy unclear , metabolic vascular factor implicate . Microvascular disease possibly initial event development diabetic complication . Microvascular disease may play important role causation exacerbation diabetic neuropathy . Histopathological study show thicken vessel wall , hyperplasia capillary endothelial cell increase plug vessel neuropathic patient . Endothelial dysfunction think important initiate factor development complication . Endothelial dysfunction think develop consequence change nitric oxide cell adhesion molecule plasma diabetic patient . L-arginine amino acid , source NO body . We therefore propose study efficacy arginine supplementation ( available counter food supplement ) endothelial function biomarkers impair endothelial function . We hope study demonstrate L-arginine supplementation enhance nitric oxide availability , thereby improve microcirculation subsequently improve peripheral nerve function . We use surrogate marker assess efficacy L-arginine supplementation show improvement diabetic complication microalbuminuria urine , TcPO2 skin low limb . In addition microcirculation assess use Moor Laser Doppler flow machine Radiometer TcPO2 device . Endothelial function also assess indirectly measure cell adhesion molecules ICAM-1 , VCAM-1 , P-selectin E-selectin . This perform use standard ELISA technique . A total 40 patient recruit study . Half randomise take food supplement L-arginine half placebo . At baseline patient clinical assessment neuropathy status lower limb , blood pressure BMI . Fasting blood glucose , lipid profile , U &amp; E 's , FBC , CRP , cell adhesion molecule nitric oxide do baseline three month later end study . The TcPO2 micro-circulation assess baseline also three month . Each twenty patient randomise L-arginine give tin contain 1 kilogram food supplement L-arginine . They take spoonful ( three gram ) L-arginine dissolve glass sugar free cold drink choice orange lemon squash . They take food three time day . The twenty patient randomise placebo receive tin contain one kilogram placebo instruction L-arginine group . 20 patient receive L-arginine powder ( 3G TDS ) 20 patient receive placebo , lactose powder ( 3G TDS ) Clinical examination part routine care : 1 . BMI , BMI calculate weight/height ( kg/m2 ) . 2 . Lying stand blood pressure measure twice , right arm use Dinamap™ ( Critikon , UK ) , rest 10 minute . Hypertension define accord WHO criterion ( systolic blood pressure ( sBP ) &gt; 140 mm Hg and/or diastolic blood pressure ( dBP ) &gt; 90 mm Hg patient current antihypertensive treatment . 3 . Overnight microalbumin excretion rate . 4 . Neuropathic Disability Score Vibration Perception threshold . Additional examination : 1 . TcPO2 right foot . 2 . Micro-circulation right foot use Moore Laser Doppler iontophoresis . Blood antecubital vein collect overnight fast rest fifteen minute supine position : 1. part routine care - FBC , U &amp; E 's , fast glucose , glycated haemoglobin , fast lipid profile 2. additional blood test - CRP , cell adhesion molecule , nitric oxide</detailed_description>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Males female diabetic patient peripheral neuropathy , aged 3065 year Type 2 diabetes ( NIDDM ) judge WHO criterion : onset diabetes mellitus age 30 year require insulin control diabetes insulin treatment initiate one year diagnosis diabetes history diabetic ketoacidosis All patient detailed history physical examination Patients ischaemic heart disease Previous stroke severe peripheral vascular disease ) Previous amputation Renal failure ( define serum creatinine &gt; 120 mmol/l ) Uncontrolled hypertension ( BP &gt; 160/90 ) Patients nitrate</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>Type 2 diabetes</keyword>
	<keyword>Peripheral neuropathy</keyword>
	<keyword>Microcirculation</keyword>
</DOC>